Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0781-2019Class II

Atellica IM 1600 Analyzer: In vitro diagnostic testing of clinical specimens -

Siemens Healthcare Diagnostics Inc. / initiated 2018-09-26 / Terminated / root cause: software

Siemens Healthcare Diagnostics, Inc. began a recall of Atellica IM 1600 Analyzer: In vitro diagnostic testing of clinical specimens - Product Usage: The Atellica Solution is a multi-component system for in vitro... on . FDA classified it as Class II and gives the reason as "Multiple Issues Identified in Atellica Solution System Software in V 1.14.2 and lower in: Atellica IM 1300 Analyzer Atellica IM 1600 Analyzer;Atellica CH 930 Analyzer; Atellica Sample Handler Prime". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0781-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Atellica IM 1600 Analyzer: In vitro diagnostic testing of clinical specimens - Product Usage: The Atellica Solution is a multi-component system for in vitro diagnostic testing of clinical specimens. The system is intended for the qualitative and quantitative analysis of various body fluids, using photometric, turbidimetric, chemiluminescent, and integrated ion selective electrode technology for clinical use. Siemens Material Number (SMN) :11066000
Product code
JIT Calibrator, Secondary
Reason for recall
Multiple Issues Identified in Atellica Solution System Software in V 1.14.2 and lower in: Atellica IM 1300 Analyzer Atellica IM 1600 Analyzer;Atellica CH 930 Analyzer; Atellica Sample Handler Prime
Root cause tag
software
FDA root cause
Software design
Action
Siemens Healthcare Diagnsotics issue an Urgent Medical Device Correction (UMDC) was issued to US customers via Fed-Ex on September 26, 2018. An Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens sites with affected customers electronically for distribution and regional reporting to their local competent authorities. The letter explains the reasons, observed behaviors, risk to health, actions to be taken. Review the letter with the Medical Director. " Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. The system will be updated with software version- SW V1.15 which resolves issues.
Quantity in commerce
264
Distribution
Worldwide distributions - US Nationwide and countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Nigeria, Norway, P.R. China, Poland, Portugal, Republic Korea, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, U.A.E., United Kingdom, Vietnam.
Product codes and lots
Software in V 1.14.2 and lower.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0781-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0780-2019Class IITerminatedVoluntary: Firm initiated
Z-0781-2019Class IITerminatedVoluntary: Firm initiated
Z-0782-2019Class IITerminatedVoluntary: Firm initiated
Z-0783-2019Class IITerminatedVoluntary: Firm initiated